Put Options

21 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $47,094 - $62,980
9,400 Added 35.34%
36,000 $226,000
Q2 2024

Aug 14, 2024

SELL
$4.05 - $5.43 $43,740 - $58,644
-10,800 Reduced 28.88%
26,600 $138,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $77,675 - $125,952
23,900 Added 177.04%
37,400 $169,000
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $27,388 - $35,178
-8,200 Reduced 37.79%
13,500 $49,000
Q3 2023

Nov 15, 2023

BUY
$3.91 - $5.45 $84,847 - $118,265
21,700 New
21,700 $89,000
Q1 2023

May 15, 2023

SELL
$3.95 - $5.63 $77,025 - $109,785
-19,500 Reduced 50.91%
18,800 $75,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $48,018 - $85,383
15,900 Added 70.98%
38,300 $202,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $66,976 - $97,439
22,400 New
22,400 $67,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $61,155 - $81,087
-15,100 Reduced 36.12%
26,700 $117,000
Q3 2021

Nov 12, 2021

SELL
$3.89 - $5.48 $207,726 - $292,632
-53,400 Reduced 56.09%
41,800 $187,000
Q2 2021

Aug 06, 2021

BUY
$3.61 - $5.45 $134,653 - $203,285
37,300 Added 64.42%
95,200 $498,000
Q1 2021

May 14, 2021

SELL
$3.14 - $6.14 $86,664 - $169,464
-27,600 Reduced 32.28%
57,900 $211,000
Q4 2020

Feb 12, 2021

BUY
$1.79 - $4.04 $92,185 - $208,060
51,500 Added 151.47%
85,500 $287,000
Q3 2020

Nov 13, 2020

SELL
$1.56 - $2.08 $6,552 - $8,736
-4,200 Reduced 10.99%
34,000 $65,000
Q2 2020

Aug 13, 2020

BUY
$0.94 - $2.21 $940 - $2,210
1,000 Added 2.69%
38,200 $69,000
Q1 2020

May 11, 2020

SELL
$0.84 - $1.76 $4,788 - $10,032
-5,700 Reduced 13.29%
37,200 $40,000
Q4 2019

Feb 12, 2020

BUY
$1.14 - $1.49 $48,905 - $63,921
42,900 New
42,900 $56,000
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $61,105 - $132,495
-60,500 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$2.28 - $3.8 $220,703 - $367,840
-96,800 Reduced 61.54%
60,500 $138,000
Q4 2017

Feb 14, 2018

SELL
$2.28 - $6.71 $15,503 - $45,628
-6,800 Reduced 4.14%
157,300 $365,000
Q3 2017

Nov 15, 2017

BUY
$1.15 - $2.29 $188,714 - $375,789
164,100
164,100 $356,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.